Cargando…
COVID-19: underpowered randomised trials, or no randomised trials?
A recently published trial of face mask use to protect against COVID-19 demonstrated a key barrier to carrying out randomised trials in public health: the need for unattainably large sample sizes. For many public health interventions, the choice is not between sufficiently powered trials and underpo...
Autor principal: | Fretheim, Atle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006114/ https://www.ncbi.nlm.nih.gov/pubmed/33781304 http://dx.doi.org/10.1186/s13063-021-05209-5 |
Ejemplares similares
-
Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
por: Haber, Noah A., et al.
Publicado: (2021) -
Correction to: Much ado about something: a response to “COVID-19: underpowered randomised trials, or no randomised trials?”
por: Haber, Noah A., et al.
Publicado: (2021) -
Unethical Conduct of Underpowered Clinical Trials
por: Habibzadeh, Farrokh
Publicado: (2013) -
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial
por: Girlanda, Francesca, et al.
Publicado: (2014) -
Remdesivir for COVID-19: challenges of underpowered studies
por: Norrie, John David
Publicado: (2020)